Toll-like receptor 7 and 9 signaling complexes (TLR7/9 signaling complexes)

The Toll-like receptor 7 and 9 (TLR7/9) signaling complexes are critical components of the innate immune system located within the membranes of endosomes and lysosomes. TLR7 is specialized in detecting single-stranded RNA (ssRNA), while TLR9 recognizes unmethylated CpG DNA motifs, both of which are characteristic of viral and bacterial pathogens. Upon ligand binding, these receptors undergo proteolytic cleavage and recruit the adapter protein MyD88, initiating a signaling cascade that leads to the production of Type I interferons and pro-inflammatory cytokines. In autoimmune diseases like systemic lupus erythematosus (SLE), these complexes mistakenly recognize self-nucleic acids, driving chronic inflammation and tissue damage. Therapeutic intervention often involves antimalarial drugs like hydroxychloroquine, which accumulate in the endolysosomal compartment and raise the pH, thereby inhibiting the activation of these signaling complexes. Modern drug development also focuses on highly specific small-molecule antagonists of TLR7 and TLR9 to treat refractory autoimmune conditions without the broad side effects of lysosomotropic agents.

Other names

Endosomal Toll-like receptor signaling pathwayTLR7/9 endosomal compartmentEndolysosomal TLR signaling complexTLR7 and TLR9 pathway

Inhibition of endosomal acidification, interference with TLR proteolytic processing, and competitive antagonism of nucleic acid binding to TLR7 and TLR9.